Cardiovascular Health

Cardiovascular health is often cited as the number one concern for people in the Western world. Marine-based Omega-3 fatty acids have been shown through years of clinical research to be important for cardiovascular health.

Supplementation of EPA and DHA fatty acids has demonstrated a positive effect on blood lipids, especially triglyceride levels, and can help keep normal cholesterol levels in balance. The American Heart Association recommends daily intake of Omega-3 fatty acids for their proven cardio-protective benefits.

EPAX 6000 TG is a highly concentrated product in an EPA/DHA ratio that is supported by numerous clinical studies to provide a highly effective product for this growing health concern.


Click here to see articles about Omega-3 and Cardiovascular Health
 
 
EPAX News & Events

Trygg Pharma AS has acquired 100 percent of the shares in EPAX AS

AALESUND, Norway (Sept. 03, 2010) — Trygg Pharma AS, a company jointly owned by Aker BioMarine ASA, a Norwegian biotechnology company, and Lindsay Goldberg, a New York-based investment fund, has acquired 100 percent of the shares in EPAX AS from Austevoll Seafood ASA. EPAX AS is a world-leading supplier of concentrated, marine-derived omega-3 formulas that target specific health conditions.

Read press release



 
 

Epax Unveils Latest Study At Issfal 2010

Leading Omega-3 supplier, EPAX AS, will present results from studies related to the treatment and prevention of metabolic syndrome and Type 2 Diabetes at the ISSFAL1 conference which runs from 29th May – 2nd June in Maastricht, Netherlands.

Read press release

 
 

EPAX invites you to explore our enviromental stewardship policy


www.epax.com/ecovision

 
 
EPAX AS
PO Box 2047
NO-6028 Aalesund, Norway

Site Map    •    Disclaimer

© Copyright 2008  EPAX AS

Tlf: +47 70 13 59 60
Fax: +47 70 13 59 61
E-mail: epax@epax.com
sales@epax.com